Invasive Meningococcal Disease in Italy: from the analysis of national data to an evidence-based vaccination strategy.
Conclusions: In the period from 2011 to 2017, the incidence of IMDs increased in Italy. The increase, although probably due to better surveillance, highlights the high level of circulation of non-B serogroups and the importance of the disease in the adult population. Our analysis supports an anti-meningococcal vaccination plan in Italy that should include the highest number of preventable serogroups and be aimed at vaccinating the whole population through a multicohort strategy.
Source: Journal of Preventive Medicine and Hygiene - Category: International Medicine & Public Health Authors: Sarah Igidbashian, Lorenzo Bertizzolo, Alessia Tognetto, Chiara Azzari, Paolo Bonanni, Paolo Castiglia, Michele Conversano, Susanna Esposito, Giovanni Gabutti, Giancarlo Icardi, Pier Luigi Lopalco, Francesco Vitale, Salvatore Parisi, Giovanni Checcucci Li Source Type: research
More News: Epidemiology | International Medicine & Public Health | Italy Health | Men | Meningitis | Meningitis Vaccine | Study | Vaccines